SCHEMBL16608656

SCHEMBL16608656

CS(=O)(=O)c1cc([C@H]2[C@H](c3ccccc3)[C@@H](c3cc(S(C)(=O)=O)nc(S(C)(=O)=O)n3)[C@H]2c2ccccc2)nc(S(C)(=O)=O)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BPTF Q12830 1/20 0.41
SDHB P21912 6/20 0.40
HPGD P15428 6/20 0.40
NPSR1 Q6W5P4 6/20 0.40
LMNA P02545 6/20 0.40
HTT P42858 5/20 0.40
KMT2A Q03164 5/20 0.40
STAT3 P40763 3/20 0.40
TP53 P04637 3/20 0.40
RAB9A P51151 3/20 0.40
HSD17B10 Q99714 3/20 0.40
TLR9 Q9NR96 2/20 0.40
S1PR4 O95977 2/20 0.40
S1PR1 P21453 2/20 0.40
MAPK1 P28482 2/20 0.40
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.40
STAT1 P42224 1/20 0.40
RIPK1 Q13546 2/20 0.38
TLR7 Q9NYK1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19772938 0.90 BPTF (0.35) BPTFSDHBHPGDNPSR1LMNA
SCHEMBL17995491 0.88 BPTF (0.34) BPTFSDHBHPGDNPSR1LMNA
SCHEMBL19772981 0.83 BPTF (0.33) BPTFSDHBHPGDNPSR1LMNA
SCHEMBL16608872 0.79 RIPK1 (0.40) BPTFSDHBHPGDNPSR1LMNA
SCHEMBL16608412 0.79 RIPK1 (0.40) BPTFSDHBHPGDNPSR1LMNA
SCHEMBL9626200 0.72 LMNA (0.52) BPTFSDHBHPGDNPSR1LMNA
SCHEMBL19772956 0.71 ADORA2A (0.34) SDHBLMNAHTTKMT2ARAB9A
SCHEMBL17995494 0.71 RIPK1 (0.34) SDHBHPGDKMT2ATP53RAB9A
SCHEMBL17995493 0.71 RIPK1 (0.34) SDHBHPGDKMT2ATP53RAB9A
SCHEMBL19772954 0.71 ADORA2A (0.34) SDHBLMNAHTTKMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015048246-A1 TETRA-ARYL CYCLOBUTANE INHIBITORS OF ANDROGEN RECEPTOR ACTION FOR THE TREATMENT OF HORMONE REFRACTORY CANCER THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2015-04-02 WO disclosed